OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase II Study With Carfilzomib, Cyclophosphamide and Dexamethasone (CCd) For Newly Diagnosed Multiple Myeloma

HTML

Year: 2013
Type: conference-abstract
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood.v122.21.685.685
Authors: Sara Bringhen, Chiara Cerrato, Maria Teresa Petrucci, Mariella Genuardi, Fabiana Gentilini, Concetta Conticello, Stefania Oliva, Lucia Pantani, Massimo Offidani, Carmela Palladino, Giulia Benevolo, Vittorio Montefusco, Monica Astolfi, Oreste Villani, Agostina Siniscalchi, Alberto Rocci, Lorenzo De Paoli, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo
Institutions: University of Turin, Sapienza University of Rome, Fondazione Gimema Onlus, Erasmus MC
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: carfilzomib, multiple myeloma, newly diagnosed multiple myeloma, elderly patients, proteasome inhibitors, cyclophosphamide, dexamethasone, combination chemotherapy, near complete response, complete response, progression-free survival, overall survival, frailty, treatment toxicity, maintenance therapy, transplant-ineligible patients, geriatric assessment, frailty index, Charlson Comorbidity Index
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2646510
Cites:
Cited by: 13
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms